Cargando…
A successful bridge to recovery with Impella 5.0 and subsequent hybrid cardiac resynchronization therapy in systemic right ventricle failure: a case report
BACKGROUND: Impella 5.0 is currently used as a temporary mechanical circulatory support device in cardiogenic shock (CS). However, Impella 5.0 implantation for the systemic right ventricle (sRV) has not been well documented. CASE SUMMARY: A 50-year-old man with atrial switch for dextro-transposition...
Autores principales: | Iwasaki, Keiichiro, Nishii, Nobuhiro, Akagi, Satoshi, Ito, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265450/ https://www.ncbi.nlm.nih.gov/pubmed/37324501 http://dx.doi.org/10.1093/ehjcr/ytad214 |
Ejemplares similares
-
Impella 5.0 supported oncological surgery as bridge to LVAD
por: Montisci, Andrea, et al.
Publicado: (2020) -
Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
por: Dalal, Pratik K., et al.
Publicado: (2019) -
Severe Left Ventricular Failure Unmanageable by Impella 5.0
por: Mano, Akiko, et al.
Publicado: (2023) -
Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
por: Gaudard, Philippe, et al.
Publicado: (2015) -
The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock
por: Tarabichi, Saeed, et al.
Publicado: (2020)